Back
Open Access

What have we learned and how can we advance antithrombotic treatment further?

Session: Exploring the universe of oral anticoagulation in patients with non-valvular atrial fibrillation: continuing the journey
Topic: Atrial fibrillation (AF)
Speaker: Professor G. Lip (Liverpool, GB)
Sponsored by BMS-Pfizer Alliance
Event: ESC Congress 2015

Congress Presentation

About the speaker

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
92 presentations
9 followers

5 more presentations in this session

Improving patient outcomes: how has the treatment landscape evolved?

Speaker: Professor P. Kirchhof (Hamburg, DE)

Access
Slides
Thumbnail

Overcoming the dilemma of stroke vs bleeding risk.

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Access
Slides
Thumbnail

Exploring real-world evidence for oral anticoagulation.

Speaker: Professor G. Lip (Liverpool, GB)

Access
Thumbnail

Optimising oral anticoagulation in routine clinical practice.

Speaker: Professor G. Montalescot (Paris, FR)

Access
Slides
Thumbnail

The journey continues: future perspectives on improving patient care.

Speaker: Professor G. Lip (Liverpool, GB)

Access
Thumbnail

Access the full session

Exploring the universe of oral anticoagulation in patients with non-valvular atrial fibrillation: continuing the journey

Speakers: Professor G. Lip, Professor P. Kirchhof, Professor S. Hohnloser, Professor G. Lip, Professor G. Montalescot...
Access
Thumbnail

About the event

Image

ESC Congress 2015

29 August - 2 September 2015

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb